Many of you are interested to know what the fund managers are buying and selling. So, let’s find out which stocks attracted the fund manager most in the month of February 2019.

The stocks that are likely to witness significant movement on the bourses on March 18 are Voltas, Natco Pharma, Aarti Drugs, Wipro and Religare Enterprises.

Come March, everyone checks out for one last time, whether their tax-saving investments for the financial year is in order. Some even try to make last-minute investments in the last week of March. Here is a list of steps to go through before making hurried investments. 

FMCG stocks on Friday showed a negative trend despite benchmark index touching fresh highs for the year 2019. The sector took cues from HUL which hinted on lower volumes growth for the fourth quarter of FY19.

Aarti Drugs announced that its board approved buyback of around 1.2 per cent equity shares. The buyback price is set at Rs. 900 per share, which is a 37 per cent premium to its, Friday, 15 March closing.

Glenmark Pharmaceuticals received ANDA approval for Clindamycin and Benzoyl Peroxide Gel. The United States Food and Drug Administration (USFDA) gave Glenmark the final approval for Clindamycin and Benzoyl Peroxide Gel, a generic version of BenzaClin Gel of Valeant Bermuda.

The stock of Trent Limited has given a breakout of ascending triangle pattern on the weekly scale along with strong volumes.

India will finally get its first Real estate investment trusts (REIT) listed on its bourses.  The initial public offering (IPO) of Embassy Office Parks REIT (Embassy REIT) will open on March 18 and closes on March 20, 2019. 

The state-owned company's initial public offering (IPO) was fully subscribed at 14:15 hours on the last day of its subscription on Friday, March 15, 2018.

Following stocks are close to their 52-weeks low as at 2.20 p.m. on March 15, 2019.